NEW YORK (GenomeWeb) – Danaher's proposed $4 billion acquisition of Cepheid has cleared antitrust requirements, Cepheid announced today.

Specifically, the firm said antitrust clearances have been received or the required waiting periods have expired in the US, Germany, Austria, and South Africa. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.